Your browser doesn't support javascript.
loading
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Wu, Yong; Tan, Cong; Weng, Wei-Wei; Deng, Yu; Zhang, Qiong-Yan; Yang, Xiao-Qun; Gan, Hua-Lei; Wang, Tao; Zhang, Pei-Pei; Xu, Mi-Die; Wang, Yi-Qin; Wang, Chao-Fu.
  • Wu Y; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Tan C; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Weng WW; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Deng Y; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Zhang QY; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Yang XQ; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Gan HL; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Wang T; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Zhang PP; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Xu MD; Department of Pathology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China; Institute of Pathology, Fudan UniversityShanghai 200032, China.
  • Wang YQ; Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University Shanghai 200011, China.
  • Wang CF; Department of Pathology, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 20025, China.
Am J Cancer Res ; 6(2): 285-99, 2016.
Article en En | MEDLINE | ID: mdl-27186403

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2016 Tipo del documento: Article